These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11330128)

  • 41. Who should protect the public? The Supreme Court and medical device regulation.
    Korobkin R
    N Engl J Med; 2007 Oct; 357(17):1680-1. PubMed ID: 17960010
    [No Abstract]   [Full Text] [Related]  

  • 42. Revisions to the general safety requirements for biological products; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(75):19431-4. PubMed ID: 10178870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Memorandum of understanding between the Food and Drug Administration and the Defense Alliance for Advanced Medical Terminology--FDA. Notice.
    Fed Regist; 1998 Jul; 63(129):36700-6. PubMed ID: 10181056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Challenges in regulating breakthrough medical devices.
    Muni NI; Gross TP; Boam AB; Wang S; Zuckerman BD
    Food Drug Law J; 2005; 60(2):137-42. PubMed ID: 16097092
    [No Abstract]   [Full Text] [Related]  

  • 45. A pivotal medical-device case.
    Sonder G
    N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18426012
    [No Abstract]   [Full Text] [Related]  

  • 46. To have (medical devices) or not: what's safer for patients?
    McCormack J
    Health Facil Manage; 1995 Jun; 8(6):44, 46, 48. PubMed ID: 10142630
    [No Abstract]   [Full Text] [Related]  

  • 47. FDA updates tubing misconnections website.
    Health Devices; 2012 Oct; 41(10):334. PubMed ID: 23444679
    [No Abstract]   [Full Text] [Related]  

  • 48. In the hot seat. Study questions FDA's fast-track process.
    McKinney M
    Mod Healthc; 2011 Feb; 41(8):16. PubMed ID: 21608192
    [No Abstract]   [Full Text] [Related]  

  • 49. Evidence strength in FDA premarket approval of cardiovascular devices.
    Kong DF; Hasselblad V; Krucoff MW
    JAMA; 2010 Apr; 303(16):1599-600; author reply 1600-1. PubMed ID: 20424248
    [No Abstract]   [Full Text] [Related]  

  • 50. The FDA's response to the GAO's report: new effort to tighten the pre-market review process for select Class III medical devices.
    Kim JH; Smith J; Greis J; Werling K
    Health Care Law Mon; 2009 May; 2009(5):2-8. PubMed ID: 19449776
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmaceuticals and medical devices: medical devices. Issue brief.
    Health Policy Tracking Service, A Service of Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-24. PubMed ID: 21374838
    [No Abstract]   [Full Text] [Related]  

  • 52. A pivotal medical-device case.
    Greenspan H
    N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18420514
    [No Abstract]   [Full Text] [Related]  

  • 53. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(17):4112-21. PubMed ID: 11010653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. More safety data sought for high-risk devices.
    Voelker R
    JAMA; 2009 May; 301(18):1867. PubMed ID: 19436007
    [No Abstract]   [Full Text] [Related]  

  • 55. A US FDA medical device update, Part II.
    Donawa ME
    Med Device Technol; 1996 Sep; 7(7):12-6, 18. PubMed ID: 10163518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmaceuticals and medical devices: medical devices.
    ; Berry MD
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-38. PubMed ID: 22403842
    [No Abstract]   [Full Text] [Related]  

  • 57. Legal overprotection.
    Friedman JH
    Med Health R I; 2004 Oct; 87(10):294. PubMed ID: 15559378
    [No Abstract]   [Full Text] [Related]  

  • 58. U.S.-Sino safety pact called 'modest start'. Experts say more must be done to ensure safe drug, medical device imports.
    Rhea S
    Mod Healthc; 2007 Dec; 37(50):12-3. PubMed ID: 18200957
    [No Abstract]   [Full Text] [Related]  

  • 59. Premarket approval supplement pathway: do we know what we are getting?
    Zheng SY; Redberg RF
    Ann Intern Med; 2014 Jun; 160(11):798-9. PubMed ID: 24664113
    [No Abstract]   [Full Text] [Related]  

  • 60. FDA recalls not as alarming as they seem.
    Connor JT; Lewis RJ; Berry DA; Berry SM
    Arch Intern Med; 2011 Jun; 171(11):1044-5; author reply 1045-6. PubMed ID: 21670380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.